Clinical analysis and evaluation of the results of adjuvant treatment (radiotherapy and chemotherapy) in XXXX .

@entity43 @entity1 @entity632 @entity5 @entity900 @entity786
The present study was carried out on the material of 486 @entity43 @entity1 who received radiotherapy and chemotherapy as adjuvant treatment at the Oncological Gynaecology Clinic at the Maria Sk  odowska-Curie @entity5 Center-Institute of Oncology in Warsaw in the period 1979-1985, following primary surgery. The clinical stage of disease advancement was determined on the basis of surgery protocols and histological examinations. Radiotherapy was the treatment of choice in @entity1 in stages I and II. Irradiation was applied to the pelvis minor and para aortal nodes (in @entity1 at stage Ia) or to fields covering the entire abdominal cavity (other @entity1 at stage I and II). Chemotherapy was given to stage III and IV @entity1 multi-drug therapy, usually including @entity900 , @entity632 , and @entity786 , or with one drug (monochemotherapy) with the alhylating agents. The largest group of @entity1 under study were @entity1 with @entity43 in stage I (38.8%), the smallest group consisted of @entity1 in stage IV (8.5%). @entity1 in stage III represented 37.5% of all the material. @entity1 aged 50-64 years were most frequently treated (47.3%), the least frequent group were the @entity1 aged over 65 (13.2%). The predominating histological diagnosis was serous cancer type (48.7%), clear-cell cancer was detected least frequently (13.2%). Among all the @entity1 treated 35.4% survived 5 years after treatment, 69% in stage I, 43.8% in stage II, 8.8% in stage III, and 2.5% in stage IV.
